CAV1 and nephrotic syndrome: Taken together, these experimental results suggested that the YBT treatment for edema in nephrotic syndrome achieved the potential effect in part by modulating the Cav-1 expression to regulate albumin transport across membranes and intercellular adhesion junctions, thereby maintaining the normal barrier function of vascular endothelial cells.